Trending:
Alzheimer’s disease and multiple sclerosis are the two most common neurology indications for which pipeline neuro-immunology drugs are being developed, primarily driven by a large patient population affected by these...
In late November, Shenzhan’s Southern University of Science and Technology researcher He Jiankui announced on YouTube that his research had resulted in the birth of the first genetically modified children.
Osteoarthritis is a progressive degenerative disease of the joints thought to affect over 30 million adults in the US.
“30% of stakeholders are not going to be prepared for serialisation,” said Rick Seibert, Senior Vice President, Innovation and Technology Services, Sharp Packaging Services at the Convention on Pharmaceutical Ingredients...
This decrease in the cost of genome sequencing is a key milestone in the development of personalised medicine that demonstrates that this can and will be a reality in the...
Alzheimer’s disease is a complex and poorly understood disorder that ultimately leads to neurodegeneration in patients afflicted with the disease.
Piramal Enterprises (Mumbai, India) is considering selling its contract manufacturing organization (CMO) subsidiary Piramal Pharma Solutions (Mumbai, India) in a $1bn deal, Bloomberg reported on 16 October 2018.
Sharp movements in exchange rates between the US dollar and major developed countries’ currencies could harm the competitiveness of future US-based CMO operations. At the same time, they might contribute...
This combination therapy is meant for patients who have other chronic health conditions or comorbidities where intensive chemotherapy is not recommended.
Stories like the NHS requiring drug makers to stockpile drugs in preparation for a “no-deal” Brexit played a part in negatively affecting industry professionals’ confidence in the UK.
Go Top
